Comparison of the Efficacies and Safety of Combined Therapy between Telbivudine Plus Adefovir and Lamivudine Plus Adefovir in Patients with Hepatitis B Virus Infection in Real-World Practice

BACKGROUND AND AIM: Chronic hepatitis B infection remains a significant health issue worldwide. This study evaluated the efficacy and safety of combined therapy using lamivudine plus adefovir (LAM+ADV) versus telbivudine plus adefovir (LdT+ADV) and the corresponding renal function change and safety....

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :PLoS One
Главные авторы: Lin, Ming-Tsung, Yen, Yi-Hao, Tsai, Ming-Chao, Tseng, Po-Lin, Chang, Kuo-Chin, Wu, Cheng-Kun, Hu, Tsung-Hui
Формат: Artigo
Язык:Inglês
Опубликовано: Public Library of Science 2016
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5091898/
https://ncbi.nlm.nih.gov/pubmed/27806120
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0165416
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы